Work

Race and sex differences in the initiation of diabetes drugs by privately insured US adults

Year: 2021

Type: article

Source: Endocrine

DOI: 10.1007/s12020-021-02710-4

Authors: Rozalina G. McCoy, Holly K. Van Houten, Shannon M. Dunlay, Xiaoxi Yao, Timothy Dempsey, Peter A. Noseworthy, Lindsey R. Sangaralingham, Andrew H. Limper, Nilay D. Shah

Institution: Mayo Clinic

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: green

Funders: U.S. Food and Drug Administration, Agency for Healthcare Research and Quality, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with Diabetes, G122417246, G1235362558, Diffusion of Clinical Evidence into Practice: Physician Networks, Delivery Organizations, and Markets, G225606699, Influence of genetic variation on QT prolongation over the lifecourse and as a cardiotoxic drug response, Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib), Optimizing stroke prevention for older adults with atrial fibrillation: Towards rigorous evaluation and judicious application of a new device, G4883553062, Understanding Caregiving in Heart Failure and Impact on Outcomes, Pairing Observational and Patient-level Clinical Trial Data to Assess Cardiovascular Risk Reduction with Catheter Ablation for Atrial Fibrillation, G747006993, Advanced Heart Failure: Epidemiology and Outcomes, Pneumocystis: Macrophage & Epithelial Activation, Georgia Center for Diabetes Translation Research, Cardiovasology

OpenAlex ID: W3147628429

FWCI: 1.678

Cites: 18

Cited by: 13

Related to: 10